相似文献
1
Chilblain lesions after COVID-19 mRNA vaccine.
Br J Dermatol. 2021 Jul;185(1):e3. doi: 10.1111/bjd.20060. Epub 2021 Apr 26.
2
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
3
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Ital J Pediatr. 2022 Jun 13;48(1):93. doi: 10.1186/s13052-022-01296-5.
4
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e630-e632. doi: 10.1111/jdv.17451. Epub 2021 Jun 30.
5
Chilblain-like Lesions after COVID-19 Vaccination: A Case Series.
Acta Derm Venereol. 2022 May 10;102:adv00711. doi: 10.2340/actadv.v102.2076.
6
Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report.
Acta Derm Venereol. 2021 Nov 10;101(11):adv00589. doi: 10.2340/00015555-3888.
7
Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
JAMA Netw Open. 2021 Jun 1;4(6):e2111369. doi: 10.1001/jamanetworkopen.2021.11369.
8
Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
Int J Dermatol. 2021 Sep;60(9):1152-1153. doi: 10.1111/ijd.15619. Epub 2021 Apr 26.
9
Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e497-e498. doi: 10.1111/jdv.18025. Epub 2022 Mar 8.
10
Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e572-e574. doi: 10.1111/jdv.16733. Epub 2020 Jul 9.
引用本文的文献
1
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.
Ann Dermatol. 2023 Nov;35(Suppl 2):S281-S286. doi: 10.5021/ad.21.307.
2
Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases.
J Taibah Univ Med Sci. 2023 Sep 5;18(6):1646-1661. doi: 10.1016/j.jtumed.2023.08.004. eCollection 2023 Dec.
3
COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report.
Clin Case Rep. 2022 Dec 27;10(12):e6790. doi: 10.1002/ccr3.6790. eCollection 2022 Dec.
4
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
5
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
6
Do we miss rare adverse events induced by COVID-19 vaccination?
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
7
Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.
Eur J Pediatr. 2022 Oct;181(10):3577-3593. doi: 10.1007/s00431-022-04585-7. Epub 2022 Aug 10.
8
Post-SARS-CoV-2 vaccination COVID toes and fingers : Two case reports and a short literature review.
Wien Med Wochenschr. 2023 Sep;173(11-12):267-269. doi: 10.1007/s10354-022-00944-z. Epub 2022 Jun 23.
9
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
10
Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination.
J Med Vasc. 2022 Feb;47(1):36-38. doi: 10.1016/j.jdmv.2022.01.072. Epub 2022 Jan 17.
本文引用的文献
1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
2
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
Zotero 插件